Overview A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia Status: Withdrawn Trial end date: 2020-06-01 Target enrollment: Participant gender: Summary This clinical trial to study the Safety and Efficacy of Autologous Mesenchymal stem cells in critical limb ischemia. Phase: Phase 1 Details Lead Sponsor: Pharmicell Co., Ltd.